Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 4:05 pm Unchanged |
2025-04-11 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 485,689 26.800% |
0 (Unchanged) |
Filing History |
| 2025-04-10 4:05 pm Purchase |
2025-03-31 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 485,689 44.300% |
485,689 (New Position) |
Filing History |
| 2024-08-14 4:40 pm Purchase |
2024-08-13 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 473,503 45.800% |
473,503 (New Position) |
Filing History |
| 2024-02-28 4:07 pm Unchanged |
2024-02-27 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 419,114 46.700% |
0 (Unchanged) |
Filing History |
| 2024-01-22 4:26 pm Purchase |
2024-01-18 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 419,114 50.900% |
20,957 (+5.26%) |
Filing History |
| 2023-12-08 5:28 pm Sale |
2023-12-04 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
EW Healthcare Partners, L.P. | 2,337,786 5.000% |
-1,312,606 (-35.96%) |
Filing History |
| 2023-10-23 4:05 pm Purchase |
2023-10-20 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 398,157 44.200% |
51,073 (+14.71%) |
Filing History |
| 2023-09-14 6:36 pm Sale |
2023-09-08 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 347,084 44.200% |
-61,625 (-15.08%) |
Filing History |
| 2023-08-30 5:22 pm Sale |
2019-03-28 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
EW Healthcare Partners, L.P. | 3,650,392 10.400% |
-540,004 (-12.89%) |
Filing History |
| 2023-07-14 3:23 pm Purchase |
2023-07-12 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 408,710 50.700% |
121,270 (+42.19%) |
Filing History |
| 2023-05-24 1:22 pm Purchase |
2023-05-15 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 287,439 42.000% |
68,155 (+31.08%) |
Filing History |
| 2022-11-29 6:04 pm Unchanged |
2022-11-18 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 219,285 40.600% |
0 (Unchanged) |
Filing History |
| 2022-11-28 5:17 pm Purchase |
2022-11-18 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 219,285 41.380% |
90,985 (+70.92%) |
Filing History |
| 2022-02-03 4:09 pm Purchase |
2022-02-03 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 128,300 35.880% |
23,852 (+22.84%) |
Filing History |
| 2021-02-12 4:36 pm Purchase |
2020-12-31 | 13D | Venus Concept Inc. VERO |
EW Healthcare Partners, L.P. | 104,447 29.520% |
24,587 (+30.79%) |
Filing History |
| 2021-02-09 2:21 pm Sale |
2020-12-31 | 13G | AxoGen, Inc. AXGN |
EW Healthcare Partners, L.P. | 1,981,888 4.940% |
-448,111 (-18.44%) |
Filing History |